14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for SAVA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 24.65 6.60 %
R2 23.88 3.27 %
R1 23.40 1.20 %
Current price: 23.12
Support S1 21.86 -5.47 %
S2 21.38 -7.53 %
S3 20.61 -10.87 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 26.11 12.93 %
R2 25.40 9.86 %
R1 23.33 0.91 %
Current price 23.12
Support S1 22.75 -1.60%
S2 20.81 -9.99%
S3 20.01 -13.45%

SAVA Predictions History

1 year ago
jdelzottodo.360231 predicted that SAVA for 2023-05-03 is going

Rank:

1 year ago
PredictionBot.Kathy predicted that SAVA for 2023-03-24 is going $24.54 (1.54%)

1 year ago
PredictionBot.Warren predicted that SAVA for 2023-03-24 is going $24.32 (0.62%)

1 year ago
AlexVel predicted that SAVA for 2023-03-24 is going $23.67 (-2.07%)

1 year ago
PredictionBot.Kathy predicted that SAVA for 2023-02-21 is going $26.12 (-3.27%)

1 year ago
PredictionBot.Warren predicted that SAVA for 2023-02-21 is going $27.55 (2.04%)

1 year ago
jdelzottodo.360231 predicted that SAVA for 2023-02-21 is going

Rank:

1 year ago
JS predicted that SAVA for 2023-01-12 is going

1 year ago
JS predicted that SAVA for 2023-01-12 is going

1 year ago
PredictionBot.Kathy predicted that SAVA for 2023-01-12 is going $34.33 (0.80%)

Click to get the best stock tips daily for free!

About Cassava Sciences Inc.

Cassava Sciences Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci... SAVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT